ZERIA PHARMACEUTICAL CO.,LTD.(4559) Summary
4559
TSE Prime
ZERIA PHARMACEUTICAL CO.,LTD.
Result
2,113
JPY
+33
(+1.59%)
Aug 14, 3:07 pm JST
13.27
USD
Aug 14, 2:07 am EDT
PER
9.3
PBR
0.86
Yield
2.37%
Margin Trading Ratio
34.71
PTS
outside of trading hours
2,112
Aug 14, 3:04 pm JST
Stock Price
Aug 14, 2026
Opening
Aug 14, 9:00 am
2,080
JPY
13.04
USD
Previous Close
Aug 13
2,080
JPY
13.04
USD
High
Aug 14, 3:04 pm
2,113
JPY
13.27
USD
Low
Aug 14, 9:29 am
2,078
JPY
13.03
USD
Volume
87,700
Trading Value
0.18B
JPY
1.15M
USD
VWAP
2095.71
JPY
13.17
USD
Minimum Trading Value
211,300
JPY
1,327
USD
Market Capitalization
0.11T
JPY
0.67B
USD
Number of Trades
341
Opening
Aug 14, 9:03 am
2,088.3
JPY
Previous Close
Aug 13
2,069.2
JPY
High
Aug 14, 3:04 pm
2,112
JPY
Low
Aug 14, 9:37 am
2,086
JPY
Volume
7,800
Trading Value
16M
JPY
VWAP
2,098.27
JPY
Minimum Trading Value
ー
Market Capitalization
ー
Number of Trades
ー
PTS Stock Price
Liquidity & Number of Trades
As of Aug 14, 2026
Liquidity
Liquidity Grade
| Liquidity | Number Of Trades | Distribution |
|---|---|---|
| High | Over 1,000 | 13.9% |
| Slightly-High | 400 to 1,000 | 18.5% |
| Mid | 50 to 400 | 39.0% |
| Slightly-Low | 10 to 50 | 17.6% |
| Low | Less than 10 | 11.0% |
Mid
1-Year Average
359
1-Year High
Feb 6, 2026
1,179
Margin Trading
| Date | Short Interest | Long Margin Positions | Ratio |
|---|---|---|---|
| Aug 7, 2026 | 2,800 | 97,200 | 34.71 |
| Jul 31, 2026 | 5,700 | 35,100 | 6.16 |
| Jul 24, 2026 | 3,600 | 44,400 | 12.33 |
| Jul 17, 2026 | 3,300 | 47,400 | 14.36 |
| Jul 10, 2026 | 10,200 | 44,200 | 4.33 |
Company Profile
ZERIA PHARMACEUTICAL CO.,LTD. is a mid-tier pharmaceutical company focusing on gastrointestinal products. It also develops over-the-counter drugs such as the nutritional supplement "Hepalyse" and is expanding overseas.
Sector
Pharmaceuticals
Website
ZERIA PHARMACEUTICAL CO.,LTD. operates with prescription pharmaceuticals as its core business, complemented by its consumer healthcare business as a dual revenue stream. In the prescription pharmaceuticals sector, the company manufactures and sells its own products domestically while pursuing international expansion through overseas subsidiaries. The consumer healthcare business encompasses a wide range of products, primarily OTC drugs, as well as health foods and cosmetics. The group consists of 22 subsidiaries and one affiliated company, through which it engages in the sale of health foods and cosmetics, and the manufacture and sale of pharmaceutical raw materials. Additionally, subsidiaries are involved in insurance agency services, real estate, procurement and sales of promotional materials, and various maintenance services. By collaborating with domestic and international subsidiaries and affiliates, ZERIA PHARMACEUTICAL CO.,LTD. has established a global business foundation.